SCHEMBL18627205

SCHEMBL18627205

C=C/C=C(C=C)/C=N/Nc1ccccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 10/20 0.44
▸ NPC1 O15118 7/20 0.44
▸ GAA P10253 7/20 0.44
▸ MAPT P10636 5/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ LMNA P02545 3/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ NCOA1 Q15788 1/20 0.44
▸ NCOA3 Q9Y6Q9 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ MEN1 O00255 6/20 0.43
▸ KMT2A Q03164 6/20 0.43
▸ HSP90AA1 P07900 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18627145 0.73 RAB9A (0.45) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL17234471 0.73 RAB9A (0.51) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL18528347 0.73 RAB9A (0.51) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL1144420 0.72 RAB9A (0.49) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL1144419 0.72 RAB9A (0.49) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL16657872 0.70 RAB9A (0.50) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL21098265 0.69 MAPT (0.52) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL24870922 0.69 RAB9A (0.56) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL12726207 0.69 RAB9A (0.56) RAB9ANPC1GAAMAPTSMN1; SMN2
SCHEMBL21369562 0.69 RAB9A (0.47) RAB9ANPC1GAAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9593103-B2 Pyridyl hydrazones for the treatment of tuberculosis and related diseases TECNIMEDE SOCIEDADE TECNICO-MEDICINAL S.A. (PT) 2017-03-14 — — US disclosed
Send feedback